Pernix Therapeutics Holdings Stocks List
|ELDN||F||Eledon Pharmaceuticals, Inc.||-0.96|
|SLGL||B||Sol-Gel Technologies Ltd.||9.70|
|OSMT||F||Osmotica Pharmaceuticals plc||3.62|
|RYJ||A||Guggenheim Raymond James SB-1 Equity Fund||0.33|
|SQLV||B||Legg Mason Small-Cap Quality Value ETF||0.14|
|IBBJ||D||Defiance Nasdaq Junior Biotechnology ETF||0.06|
|BIB||D||ProShares Ultra Nasdaq Biotechnology||0.02|
|IBB||D||iShares Nasdaq Biotechnology Index Fund||0.02|
View all Pernix Therapeutics Holdings related ETFs...
Pernix Therapeutics (NASDAQ: PTX) is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and psychiatry, and has an interest in expanding into additional specialty segments. The Company promotes its branded products to physicians through its Pernix sales force, uses contracted sales organizations to market its non-core, cough and cold products, and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceutical, LLC and Cypress Pharmaceuticals, Inc.